- Home
- MNPR vs WOLF Comparison
MNPR vs WOLF Comparison
Compare MNPR & WOLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- WOLF
- Stock Information
- Founded
- MNPR 2014
- WOLF 1987
- Country
- MNPR United States
- WOLF United States
- Employees
- MNPR N/A
- WOLF N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- WOLF Semiconductors
- Sector
- MNPR Health Care
- WOLF Technology
- Exchange
- MNPR Nasdaq
- WOLF Nasdaq
- Market Cap
- MNPR 209.3M
- WOLF 200.8M
- IPO Year
- MNPR 2019
- WOLF 1993
- Fundamental
- Price
- MNPR $44.97
- WOLF $1.64
- Analyst Decision
- MNPR Strong Buy
- WOLF Hold
- Analyst Count
- MNPR 7
- WOLF 13
- Target Price
- MNPR $62.00
- WOLF $10.21
- AVG Volume (30 Days)
- MNPR 69.5K
- WOLF 127.8M
- Earning Date
- MNPR 08-08-2025
- WOLF 08-20-2025
- Dividend Yield
- MNPR N/A
- WOLF N/A
- EPS Growth
- MNPR N/A
- WOLF N/A
- EPS
- MNPR N/A
- WOLF N/A
- Revenue
- MNPR N/A
- WOLF $761,300,000.00
- Revenue This Year
- MNPR N/A
- WOLF N/A
- Revenue Next Year
- MNPR N/A
- WOLF $14.42
- P/E Ratio
- MNPR N/A
- WOLF N/A
- Revenue Growth
- MNPR N/A
- WOLF N/A
- 52 Week Low
- MNPR $1.72
- WOLF $0.39
- 52 Week High
- MNPR $54.30
- WOLF $3.33
- Technical
- Relative Strength Index (RSI)
- MNPR 59.21
- WOLF 52.60
- Support Level
- MNPR $44.26
- WOLF $1.41
- Resistance Level
- MNPR $47.52
- WOLF $2.05
- Average True Range (ATR)
- MNPR 3.49
- WOLF 0.38
- MACD
- MNPR 0.54
- WOLF 0.05
- Stochastic Oscillator
- MNPR 64.49
- WOLF 18.51
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About WOLF Wolfspeed Inc.
Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.